Rocket Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Rocket Pharmaceuticals Inc cash flow-to-debt ratio. Rocket Pharmaceuticals Inc (RCKT) has a Cash Flow-to-Debt Ratio of -0.73x as of June 2026, meaning its operating cash flow of $-39.61 Million could theoretically repay -1% of its total liabilities ($54.27 Million) in one year. Check RCKT cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Rocket Pharmaceuticals Inc (2012–2025)
Cash flow-to-debt ratio of Rocket Pharmaceuticals Inc from 2012 to 2025. Historical debt coverage capacity for Rocket Pharmaceuticals Inc across 14 annual periods. Also explore Rocket Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Rocket Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Rocket Pharmaceuticals Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Rocket Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Rocket Pharmaceuticals Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.57x | $-190.01 Million | $53.23 Million | ▼ -9.7% |
| 2024 | -3.25x | $-209.72 Million | $64.47 Million | ▼ -23.1% |
| 2023 | -2.64x | $-194.92 Million | $73.77 Million | ▲ +7.9% |
| 2022 | -2.87x | $-178.14 Million | $62.12 Million | ▼ -0.1% |
| 2021 | -2.86x | $-121.16 Million | $42.30 Million | ▼ -235.1% |
| 2020 | -0.85x | $-74.64 Million | $87.31 Million | ▲ +14.3% |
| 2019 | -1.00x | $-64.66 Million | $64.82 Million | ▼ -6.2% |
| 2018 | -0.94x | $-53.79 Million | $57.28 Million | ▼ -94.3% |
| 2017 | -0.48x | $-26.11 Million | $54.01 Million | ▲ +26.7% |
| 2016 | -0.66x | $-37.27 Million | $56.48 Million | ▲ +82.9% |
| 2015 | -3.86x | $-17.42 Million | $4.51 Million | ▼ -2163.3% |
| 2014 | -0.17x | $-9.74 Million | $57.08 Million | ▼ -36.9% |
| 2013 | -0.12x | $-6.46 Million | $51.76 Million | ▲ +41.8% |
| 2012 | -0.21x | $-6.94 Million | $32.35 Million | — |